MEDBOLIDE PHARMA JSC PARTNERS WITH THE 8TH ANNUAL SCIENTIFIC CONFERENCE — NATIONAL MENTAL HOSPITAL II

On July 31, 2026, the 8th Annual Scientific Conference, organized by National Mental Hospital II under the theme “Innovating and Enhancing the Quality of Comprehensive Mental Health Care in the Digital Age,” was successfully held. The conference brought together a large number of experts, scientists, representatives from the Dong Nai Department of Health, leaders of provincial-level psychiatric hospitals, as well as healthcare facilities and medical staff working in the field of mental health care nationwide.

According to Dr. Nguyen Huu Thang, Director of National Mental Hospital No. 2, the Annual Scientific Conference serves as a forum for scientists, experts, and healthcare professionals to share research findings, learn about the latest advances in the field of psychiatry, and exchange practical experiences, thereby helping to improve the quality of diagnosis and treatment and promote the development of psychiatry in Vietnam.

At the conference, a presentation was given on the topic “RIDTON (Rivastigmine 1.5 mg) – A SOLUTION FOR THE TREATMENT OF DEMENTIA CAUSED BY ALZHEIMER’S AND PARKINSON’S DISEASE” by a representative from Medbolide Pharma JSC. The presentation discussed the active ingredient Rivastigmine, highlighting the following key points:

• Dual-action mechanism: Dual inhibition of cholinesterase (AchE & BuChE)
• Broad spectrum of indications: Rivastigmine treats dementia caused by Alzheimer’s disease and Parkinson’s disease
• Rivastigmine improves activities of daily living and overall functioning
• Rivastigmine does not interact with drugs metabolized by CYP450

In addition, Medbolide Pharma JSC participated as a sponsor with a booth showcasing its products: LERFOZI (Trazodone), FLIBGA (Meclizine), POZIAT 5 (Aripiprazole), and MAFOXA (Ziprasidone). The booth received significant attention and high praise from attendees regarding the therapeutic efficacy and safety of the products. 

Guided by the motto “Quality First,” Medbolide’s participation in the conference not only demonstrates the company’s role and responsibility in improving public health, but also serves as an opportunity to stay up to date on and share the latest medical knowledge, thereby contributing to the development of high-quality medical products.